Who has been buying Kringle Pharma, Inc. stock?

11 distinct investors have filed 44 disclosed large-shareholding filings in Kringle Pharma, Inc. (4884), most recently on 2026-04-09. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Kringle Pharma, Inc. have?

Kringle Pharma, Inc. has 44 buy-side and 35 sell-side disclosures on record, covering ¥10.7B ($69.2M) in total reported value, spanning 2021-11-08 to 2026-04-09.

Where does StockDrifts get Kringle Pharma, Inc. insider data?

From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.

Do insider buys in Japanese stocks predict returns?

Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Kringle Pharma, Inc. 4884

Company

クリングルファーマ株式会社Kringle Pharma, Inc.

Investors

Buys

Total Value

¥10.7B ($69.2M)

Avg Return

-28.60%

Last Filing

2026-04-09

Kringle Pharma, Inc. (4884) has 44 disclosed large-shareholding filings and 35 disclosed disposals on record, filed by 11 distinct investors. Together those filings cover ¥10.7B ($69.2M) in reported transaction value. The earliest filing StockDrifts holds for Kringle Pharma, Inc. is dated 2021-11-08; the most recent is 2026-04-09. All of it is parsed from EDINET large-shareholding (5%+) reports, the official disclosure system operated by the Financial Services Agency (Japan). Across these filings the average return since disclosure is -28.60%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

Date	Type	Source	Insider	Purpose	Shares	Price at filing	Return	Value
2026-06-05	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥334	+1.5%	-
2026-06-05	SELL	private	エボファンド Evo Fund	activist	516.3K	¥334	-1.5%	¥4M ($29K)
2026-05-29	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥393	-19.1%	-
2026-05-29	SELL	private	エボファンド Evo Fund	activist	530.1K	¥393	+19.1%	¥40M ($256K)
2026-05-25	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥426	-27.2%	-
2026-05-25	SELL	private	エボファンド Evo Fund	activist	635.4K	¥426	+27.2%	¥37M ($239K)
2026-05-20	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥408	-25.7%	-
2026-05-20	SELL	private	エボファンド Evo Fund	activist	726.0K	¥408	+25.7%	¥37M ($236K)
2026-05-20	SELL	private	エボファンド Evo Fund	activist	726.0K	¥408	+25.7%	¥37M ($236K)
2026-05-20	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥408	-25.7%	-
2026-04-09	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥464	+1.5%	-
2026-04-09	SELL	private	エボファンド Evo Fund	activist	821.7K	¥464	-1.5%	¥136M ($880K)
2026-04-08	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥446	+5.6%	-
2026-04-08	SELL	private	エボファンド Evo Fund	activist	1.1M	¥446	-5.6%	¥157M ($1.0M)
2026-03-18	BUY	private	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥397	-21.2%	-
2026-03-18	SELL	private	エボファンド Evo Fund	activist	1.5M	¥397	-21.2%	¥725M ($4.7M)
2025-12-03	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥391	-23.0%	-
2025-12-03	SELL	Market Buy	エボファンド Evo Fund	activist	1.6M	¥391	-23.0%	¥766M ($4.9M)
2025-10-16	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥453	+6.2%	-
2025-10-16	SELL	Market Buy	エボファンド Evo Fund	activist	1.7M	¥453	-6.2%	¥8M ($52K)
2025-10-15	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥452	+6.4%	-
2025-10-15	SELL	Market Buy	エボファンド Evo Fund	activist	1.7M	¥452	-6.4%	¥38M ($242K)
2025-09-24	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥486	-1.0%	-
2025-09-24	SELL	Market Buy	エボファンド Evo Fund	activist	1.8M	¥486	+1.0%	¥33M ($215K)
2025-08-22	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥487	-1.2%	-
2025-08-22	SELL	Market Buy	エボファンド Evo Fund	activist	1.9M	¥487	+1.2%	¥35M ($224K)
2025-08-08	BUY	Market Buy	エボファンド Evo Fund	activist	2.0M	¥493	-2.4%	¥989M ($6.4M)
2025-08-08	BUY	Market Buy	エボリューション・キャピタル・マネジメント・エルエルシー Evolution Capital Management LLC	passive	0	¥493	-2.4%	-
2024-07-05	SELL	Market Buy	東北大学ベンチャーパートナーズ株式会社 TOHOKU University Venture Partners	passive	208.7K	¥1,063	+54.8%	¥144M ($928K)
2024-02-19	BUY	unknown	バークレイズ証券株式会社 Barclays Securities Co., Ltd.	other	4.0K	¥417	+15.3%	¥2M ($10K)
2024-02-19	SELL	unknown	バークレイズ・キャピタル・セキュリティーズ・リミテッド Barclays Capital Securities Ltd.	other	13.1K	¥417	-15.3%	¥7M ($46K)
2024-02-19	BUY	unknown	バークレイズ・バンク・ピーエルシー Barclays Bank PLC	other	289.1K	¥417	+15.3%	¥114M ($734K)
2024-01-29	BUY	unknown	バークレイズ・バンク・ピーエルシー Barclays Bank PLC	other	374.0K	¥749	-35.8%	¥261M ($1.7M)
2024-01-29	BUY	unknown	バークレイズ証券株式会社 Barclays Securities Co., Ltd.	other	0	¥749	-35.8%	-
2024-01-29	BUY	unknown	バークレイズ・キャピタル・セキュリティーズ・リミテッド Barclays Capital Securities Ltd.	other	30.1K	¥749	-35.8%	¥10M ($64K)
2024-01-15	BUY	unknown	バークレイズ証券株式会社 Barclays Securities Co., Ltd.	other	0	¥790	-39.1%	-
2024-01-15	SELL	unknown	バークレイズ・キャピタル・セキュリティーズ・リミテッド Barclays Capital Securities Ltd.	other	16.6K	¥790	+39.1%	¥956K ($6K)
2024-01-15	BUY	unknown	バークレイズ・バンク・ピーエルシー Barclays Bank PLC	other	471.7K	¥790	-39.1%	¥341M ($2.2M)
2023-12-27	BUY	unknown	バークレイズ証券株式会社 Barclays Securities Co., Ltd.	other	0	¥723	-33.5%	-
2023-12-27	SELL	unknown	バークレイズ・キャピタル・セキュリティーズ・リミテッド Barclays Capital Securities Ltd.	other	16.2K	¥723	+33.5%	¥2M ($10K)
2023-12-27	BUY	unknown	バークレイズ・バンク・ピーエルシー Barclays Bank PLC	other	563.2K	¥723	-33.5%	¥366M ($2.4M)
2023-12-21	BUY	unknown	バークレイズ証券株式会社 Barclays Securities Co., Ltd.	other	0	¥695	-30.8%	-
2023-12-21	SELL	unknown	バークレイズ・キャピタル・セキュリティーズ・リミテッド Barclays Capital Securities Ltd.	other	18.7K	¥695	+30.8%	¥3M ($18K)
2023-12-21	BUY	unknown	バークレイズ・バンク・ピーエルシー Barclays Bank PLC	other	639.2K	¥695	-30.8%	¥395M ($2.5M)
2023-12-11	SELL	unknown	バークレイズ・キャピタル・セキュリティーズ・リミテッド Barclays Capital Securities Ltd.	other	22.7K	¥735	+34.6%	¥396M ($2.6M)
2023-12-11	SELL	unknown	バークレイズ証券株式会社 Barclays Securities Co., Ltd.	other	0	¥735	+34.6%	¥248M ($1.6M)
2023-12-11	BUY	unknown	バークレイズ・バンク・ピーエルシー Barclays Bank PLC	other	710.4K	¥735	-34.6%	¥459M ($3.0M)
2023-12-06	BUY	unknown	バークレイズ証券株式会社 Barclays Securities Co., Ltd.	other	3.6K	¥766	-37.2%	¥3M ($17K)
2023-12-06	BUY	unknown	バークレイズ・キャピタル・セキュリティーズ・リミテッド Barclays Capital Securities Ltd.	other	5.7K	¥766	-37.2%	¥4M ($27K)
2023-12-06	BUY	unknown	バークレイズ・バンク・ピーエルシー Barclays Bank PLC	other	761.4K	¥766	-37.2%	¥5M ($33K)

Showing the 50 most recent of 112 filings.

Frequently asked questions

Who has been buying Kringle Pharma, Inc. stock?: 11 distinct investors have filed 44 disclosed large-shareholding filings in Kringle Pharma, Inc. (4884), most recently on 2026-04-09. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kringle Pharma, Inc. have?: Kringle Pharma, Inc. has 44 buy-side and 35 sell-side disclosures on record, covering ¥10.7B ($69.2M) in total reported value, spanning 2021-11-08 to 2026-04-09.
Where does StockDrifts get Kringle Pharma, Inc. insider data?: From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.
Do insider buys in Japanese stocks predict returns?: Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Source filings

Every trade listed above is disclosed in EDINET large-shareholding (5%+) reports, filed with the Financial Services Agency (Japan). View the original EDINET filings for Kringle Pharma, Inc.. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.